The EASI-SWITCH trial: Early switch to oral antibiotic therapy in patients with low risk neutropenic sepsis.

TPS10143Background: Neutropenic sepsis is a common complication of systemic anti-cancer treatment (SACT) with management determined by the risk of developing septic complications. The UK National Institute for Health and Care Excellence were unable to recommend switching from empirical intravenous (IV) to oral antibiotics at 380C, neutrophil count ≤ 0.5x109/l, MASCC (Multinational Association of Supportive Care in...